FIELD: medicine, hormones, chemistry of peptides.
SUBSTANCE: invention describes compound of the formula: cyclo-[{4-NH2-C2H4-NH-CO-O-)-Pro}-Phg-D-Trp-Lys-Tyr-(4-Bzl)-Phe] being not obligatory in protected form, or its pharmaceutically acceptable salt of complex. Compound possesses the inhibitory activity on release of the growth hormone and insulin.
EFFECT: valuable medicinal properties of peptide.
9 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2355418C2 |
SOMATOSTATINE PEPTIDES | 1996 |
|
RU2160741C2 |
PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
DEPOT FORM OF SOMATOSTATIN ANALOGUE AND METHOD FOR MAKING THEREOF | 2005 |
|
RU2411031C2 |
OBTAINING OF SOMOSTATIN PEPTIDES | 2004 |
|
RU2360921C2 |
BISPHOSPHONATE-INCLUDING COMPOSITION WITH RETARDED RELEASE | 2005 |
|
RU2395274C2 |
CHIMERIC EQUIVALENTS OF LIGANS OF SOMATOSTATIN AND DOPERMINE RECEPTORS, PHARMACEUTICAL COMPOSITIONS BASED ON THEM AND MODALTIES OF SOMATOSTATIN AND/DOPERMINE RECEPTORS | 2004 |
|
RU2329273C2 |
MICROPARTICLES CONTAINING ANALOGS OF SOMATOSTATIN | 2004 |
|
RU2404749C2 |
COMBINATION OF SOMATOSTATIN ANALOGUES WITH VARIED SELECTIVITY WITH REGARD TO HUMAN SOMATOSTATIN RECEPTORS SUBTYPES | 2007 |
|
RU2451520C2 |
USING SOMATOSTATIN ANALOGUES IN MENINGIOMA | 2008 |
|
RU2523416C2 |
Authors
Dates
2006-11-20—Published
2001-07-30—Filed